The purpose of the VF Research Program is to provide one- or two-year seed grants to support pilot studies in researching: Etiology/Pathogenesis (could include a broad range of studies of immunity, inflammation, or vascular biology); Epidemiology, including genetics; Diagnosis, including identification of disease subtypes; Treatment/Management, including therapeutics to treat vasculitis or prevent complications, biomarkers, and psychosocial outcomes. Maximum awards will be $50,000 for 12 months. Investigators from Canada, USA, and Austria won the award last year. As the deadline is two weeks away, we are reaching out to see if your Rheumatology society members are interested. The details can be perused at: VF Grant for Vasculitis Research
Disclaimer: You are receiving this email as determined by the sponsor or by our Scientific Affairs. Trialect Inc. is a United States Incorporation, which posts grants, courses, fellowships, clinical trials, medical tourism and partnership opportunities exclusively for health professionals in industry and academia. While Trialect partners with various non-profits and pharmaceutical companies, we are in no way affiliated with, maintained, sponsored or endorsed by any of them. Please do not hesitate to copy and paste “unsubscribe” in subject line and respond should you wish to not receive opportunity updates from us. If you received this in error or you’ve already received this email, please disregard this correspondence. In case you have any difficulty accessing the links provided above, please feel free to Google for Trialect and search for the opportunity.